All
1.
In utero exposure to low dose arsenic via drinking water impairs early life lung mechanics in mice
Kathryn A Ramsey, Alexander N Larcombe, Peter D Sly, Graeme R Zosky BMC Pharmacology and Toxicology 2013, 14 :13 (18 February 2013)
Abstract | Full text | PDF | PubMed
2.
Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points
Jessica Stahl, Mareike Wohlert, Manfred Kietzmann BMC Pharmacology and Toxicology 2012, 13 :5 (13 August 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Microneedle rollers enhance the delivery of topically applied non-steroidal anti-inflammatory drugs and represent a valuable tool for percutaneous permeation enhancement, particularly for hydrophilic substances or those with high melting points.
3.
Exploring the relationship between safety culture and reported dispensing errors in a large sample of Swedish community pharmacies
Annika Nordén-Hägg, Sofia Kälvemark-Sporrong, Åsa Lindblad BMC Pharmacology and Toxicology 2012, 13 :4 (13 August 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Safety Attitudes Questionnaire (SAQ) responses from Swedish community pharmacies indicate no correlation between safety culture and dispensing errors, while stress recognition, age and education country diversity were associated with reported dispensing errors.
4.
Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
Elizabeth C Moylan, Christopher Morrey, Joanne M Appleford-Cook BMC Pharmacology and Toxicology 2012, 13 :1 (13 August 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
BMC Pharmacology and BMC Clinical Pharmacology are joining forces to form BMC Pharmacology and Toxicology with an expanded scope that will
facilitate connections between pre-clinical and clinical research in this era of translational medicine.
5.
Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data
Vivienne J Zhu, Anne Belsito, Wanzhu Tu, J Overhage BMC Clinical Pharmacology 2012, 12 :12 (22 June 2012)
Abstract | Full text | PDF | PubMed
6.
A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri Lanka
S M D K Ganga Senarathna, Shalini Ranganathan, Nick Buckley, Rohini Fernandopulle BMC Clinical Pharmacology 2012, 12 :6 (22 February 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
7.
Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Min-Wei Huang, Tsung-Tsair Yang, Po-Ren Ten, Po-Wen Su, Bo-Jian Wu, Chin-Hong Chan, Tsuo-Hung Lan, I-Chao Liu, Wei-Cheh Chiu, Chun-Ying Li, Kuo-Sheng Cheng, Yu-Chi Yeh BMC Clinical Pharmacology 2012, 12 :1 (6 January 2012)
Abstract | Full text | PDF | PubMed
8.
Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulation
Bernd Liedert, Ulf Forssmann, Peter Wolna, Michaela Golob, Andreas Kovar BMC Clinical Pharmacology 2010, 10 :14 (20 October 2010)
Abstract | Full text | PDF | PubMed
9.
Traumeel S® for pain relief following hallux valgus surgery: a randomized controlled trial
Shepherd R Singer, Michal Amit-Kohn, Samuel Weiss, Jonathan Rosenblum, Guy Maoz, Noah Samuels, Esther Lukasiewicz, Laurence Freedman, Ora Paltiel, Menachem Itzchaki, Meir Niska, Menachem Oberbaum BMC Clinical Pharmacology 2010, 10 :9 (12 April 2010)
Abstract | Full text | PDF | PubMed |
10.
Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study
Gunar Stemer, Sonja Zehetmayer, Rosa Lemmens-Gruber BMC Clinical Pharmacology 2009, 9 :15 (6 September 2009)
Abstract | Full text | PDF | PubMed
11.
Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series
Darren M Roberts, Renate Heilmair, Nick A Buckley, Andrew H Dawson, Mohamed Fahim, Michael Eddleston, Peter Eyer BMC Clinical Pharmacology 2009, 9 :3 (16 February 2009)
Abstract | Full text | PDF | PubMed
12.
Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin
MA Karsdal, I Byrjalsen, BJ Riis, C Christiansen BMC Clinical Pharmacology 2008, 8 :12 (4 December 2008)
Abstract | Full text | PDF | PubMed
13.
Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin
Morten A Karsdal, Inger Byrjalsen, Bente J Riis, Claus Christiansen BMC Clinical Pharmacology 2008, 8 :5 (9 September 2008)
Abstract | Full text | PDF | PubMed
14.
The Clinical Pharmacology of Intranasal l-Methamphetamine
John E Mendelson, Dana McGlothlin, Debra S Harris, Elyse Foster, Tom Everhart, Peyton Jacob, Reese T Jones BMC Clinical Pharmacology 2008, 8 :4 (21 July 2008)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Over-the-counter nasal sprays containing l-methamphetamine, an isomer of the highly addictive drug d-methamphetamine, do not produce major dose-dependent psychological effects, and produce only minor changes in blood pressure.
15.
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell® )
Bertrand Dautzenberg, Mitchell Nides, Jean-Luc Kienzler, Anne Callens BMC Clinical Pharmacology 2007, 7 :11 (8 October 2007)
Abstract | Full text | PDF | PubMed
16.
Pharmacokinetics of recombinant human growth hormone administered by cool.click™ 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle
Chris Brearley, Anthony Priestley, James Leighton-Scott, Michel Christen BMC Clinical Pharmacology 2007, 7 :10 (8 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
17.
Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone
Gayatri Sathyan, Emily Xu, John Thipphawong, Suneel K Gupta BMC Clinical Pharmacology 2007, 7 :3 (2 February 2007)
Abstract | Full text | PDF | PubMed
18.
Pharmacokinetic profile of a 24-hour controlled-release OROS® formulation of hydromorphone in the presence and absence of food
Gayatri Sathyan, Emily Xu, John Thipphawong, Suneel K Gupta BMC Clinical Pharmacology 2007, 7 :2 (2 February 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
19.
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
Anders Andersen, David J Warren, Paal F Brunsvig, Steinar Aamdal, Gunnar B Kristensen, Harald Olsen BMC Clinical Pharmacology 2006, 6 :2 (13 January 2006)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
A high performance liquid chromatography method which uses UV detection is capable of quantifying nM concentrations of taxanes in human plasma samples, making it suitable for the sensitive monitoring of taxane levels in people receiving low dose therapy for cancer treatment.
20.
Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
Pål Klepstad, Priscilla Hilton, Jorunn Moen, Stein Kaasa, Petter C Borchgrevink, Kolbjørn Zahlsen, Ola Dale BMC Clinical Pharmacology 2004, 4 :7 (4 October 2004)
Abstract | Full text | PDF | PubMed
21.
Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: A case report
Imran Mohammed, Asif Hussain BMC Clinical Pharmacology 2004, 4 :6 (9 August 2004)
Abstract | Full text | PDF | PubMed
22.
Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro
Harald Olsen, Anders Andersen, Arve Nordbø, Ulf E Kongsgaard, Ole P Børmer BMC Clinical Pharmacology 2004, 4 :4 (29 March 2004)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Pharmaceutical-grade albumin solutions display lower binding capacity for warfarin, digitoxin and naproxen compared to native human serum and commercial albumin; the stabilisers caprylic acid and N-acetyl-DL-tryptophan are implicated.
23.
An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use
Alexandra Ward, J Jaime Caro, Traci Green, Krista Huybrechts, Alejandro Arana, Suzanne Wait, Androulla Eleftheriou BMC Clinical Pharmacology 2002, 2 :3 (23 April 2002)
Abstract | Full text | PDF | PubMed
24.
Diclofenac does not interact with codeine metabolism in vivo: A study in healthy volunteers
Susanne Ammon, Claudia Marx, Christoph Behrens, Ute Hofmann, Thomas Mürdter, Ernst-Ulrich Griese, Gerd Mikus BMC Clinical Pharmacology 2002, 2 :2 (27 February 2002)
Abstract | Full text | PDF | PubMed